BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 21763633)

  • 21. A pericentric inv(9)(p22q34) of the der(9)t(9;22)(q34;q11.2) is a recurrent secondary anomaly in Ph-positive leukemia.
    Pan J; Xue Y; Qiu H; Chen S; Zhang J; Wu Y; Shen J; Wang Y
    Cancer Genet Cytogenet; 2010 Dec; 203(2):333-40. PubMed ID: 21156255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular characterization of 16p deletions associated with inversion 16 defines the critical fusion for leukemogenesis.
    Marlton P; Claxton DF; Liu P; Estey EH; Beran M; LeBeau M; Testa JR; Collins FS; Rowley JD; Siciliano MJ
    Blood; 1995 Feb; 85(3):772-9. PubMed ID: 7833479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chromosome 16 inversion-associated translocations in acute myeloid leukemia elucidated using a dual-color CBFB DNA probe.
    Aventín A; Espadaler M; Casas S; Duarte J; Nomdedéu J; Sierra J
    Cancer Genet Cytogenet; 2002 Apr; 134(2):142-4. PubMed ID: 12034528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of CBFB/MYH11 transcripts in patients with inversion and other abnormalities of chromosome 16 at presentation and remission.
    Tobal K; Johnson PR; Saunders MJ; Harrison CJ; Liu Yin JA
    Br J Haematol; 1995 Sep; 91(1):104-8. PubMed ID: 7577615
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Most Myeloid Neoplasms With Deletion of Chromosome 16q Are Distinct From Acute Myeloid Leukemia With Inv(16)(p13.1q22): A Bone Marrow Pathology Group Multicenter Study.
    Rogers HJ; Hsi ED; Tang G; Wang SA; Bueso-Ramos CE; Lubin D; Morrissette JJ; Bagg A; Cherukuri DP; George TI; Peterson L; Liu YC; Mathew S; Orazi A; Hasserjian RP
    Am J Clin Pathol; 2017 Apr; 147(4):411-419. PubMed ID: 28375434
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simple method for detection of MYH11 DNA rearrangements in patients with inv(16)(p13q22) and acute myeloid leukemia.
    van der Reijden BA; Martinet D; Dauwerse JG; Giles RH; Wessels JW; Beverstock GC; Smit B; Mühlematter D; Jotterand Bellomo M; Gabert J; Lafage-Pochitaloff M; Reiffers J; Bilhou-Nabera C; van Ommen GJ; Hagemeijer A; Breuning MH
    Leukemia; 1996 Sep; 10(9):1459-62. PubMed ID: 8751463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute myeloid leukemia with inv(16)(p13.1q22) and deletion of the 5'MYH11/3'CBFB gene fusion: a report of two cases and literature review.
    Lv L; Yu J; Qi Z
    Mol Cytogenet; 2020; 13():4. PubMed ID: 32015759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical aspects of expression of inversion 16 chromosomal fusion transcript CBFB/MYH11 in acute myelogenous leukemia subtype M1 with abnormal bone marrow eosinophilia.
    Monahan BP; Rector JT; Liu PP; Cotelingam JD; Dahut W
    Leukemia; 1996 Oct; 10(10):1653-4. PubMed ID: 8847901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rare CBFB-MYH11 fusion transcripts in AML with inv(16)/t(16;16) are associated with therapy-related AML M4eo, atypical cytomorphology, atypical immunophenotype, atypical additional chromosomal rearrangements and low white blood cell count: a study on 162 patients.
    Schnittger S; Bacher U; Haferlach C; Kern W; Haferlach T
    Leukemia; 2007 Apr; 21(4):725-31. PubMed ID: 17287858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute myeloid leukemia with t(16;16) (p13;q22) showing a new CBFB-MYH11 fusion transcript associated with an atypical leukemic blasts morphology.
    Albano F; Anelli L; Zagaria A; Coccaro N; Tota G; Impera L; Minervini CF; Cellamare A; Delia M; Minervini A; Casieri P; Specchia G
    Hum Pathol; 2014 Mar; 45(3):643-7. PubMed ID: 24342433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection and quantification of CBFB/MYH11 fusion transcripts in patients with inv(16)-positive acute myeloblastic leukemia by real-time RT-PCR.
    Krauter J; Hoellge W; Wattjes MP; Nagel S; Heidenreich O; Bunjes D; Ganser A; Heil G
    Genes Chromosomes Cancer; 2001 Apr; 30(4):342-8. PubMed ID: 11241787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. inv(16)(p13q22) in chronic myelogenous leukemia in blast phase: a clinicopathologic, cytogenetic, and molecular study of five cases.
    Merzianu M; Medeiros LJ; Cortes J; Yin C; Lin P; Jones D; Glassman A; Kantarjian H; Huh Y
    Am J Clin Pathol; 2005 Nov; 124(5):807-14. PubMed ID: 16203287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of fusion transcripts generated by the inversion 16 chromosome in acute myelogenous leukemia.
    Claxton DF; Liu P; Hsu HB; Marlton P; Hester J; Collins F; Deisseroth AB; Rowley JD; Siciliano MJ
    Blood; 1994 Apr; 83(7):1750-6. PubMed ID: 8142642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Study of trisomy 22 and inversion 16 in acute myeloid leukemia].
    Zhou HF; Li JY; Pan JL; Qiu HR; Chen LJ; Hu JY; Shen YF; Xu W; Xue YQ
    Zhonghua Xue Ye Xue Za Zhi; 2007 Jan; 28(1):11-4. PubMed ID: 17649718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Granulocytic sarcoma of mesentery in acute myeloid leukemia with CBFB/MYH11 fusion gene but not inv(16) chromosome: case report and review of literature.
    Fujieda A; Nishii K; Tamaru T; Otsuki S; Kobayashi K; Monma F; Ohishi K; Nakase K; Katayama N; Shiku H
    Leuk Res; 2006 Aug; 30(8):1053-7. PubMed ID: 16504290
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of a dual-color, double fusion FISH assay to detect RPN1/EVI1 gene fusion associated with inv(3), t(3;3), and ins(3;3) in patients with myelodysplasia and acute myeloid leukemia.
    Shearer BM; Sukov WR; Flynn HC; Knudson RA; Ketterling RP
    Am J Hematol; 2010 Aug; 85(8):569-74. PubMed ID: 20556821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trisomy 22 as the sole abnormality is an important marker for the diagnosis of acute myeloid leukemia with inversion 16.
    Xu W; Zhou HF; Fan L; Qian SX; Chen LJ; Qiu HR; Zhang SJ; Li JY
    Onkologie; 2008 Sep; 31(8-9):440-4. PubMed ID: 18787351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genomic acute myeloid leukemia-associated inv(16)(p13q22) breakpoints are tightly clustered.
    van der Reijden BA; Dauwerse HG; Giles RH; Jagmohan-Changur S; Wijmenga C; Liu PP; Smit B; Wessels HW; Beverstock GC; Jotterand-Bellomo M; Martinet D; Mühlematter D; Lafage-Pochitaloff M; Gabert J; Reiffers J; Bilhou-Nabera C; van Ommen GJ; Hagemeijer A; Breuning MH
    Oncogene; 1999 Jan; 18(2):543-50. PubMed ID: 9927211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 3'CBFbeta deletion associated with inv(16) in acute myeloid leukemia.
    Kelly J; Foot NJ; Conneally E; Enright H; Humphreys M; Saunders K; Neat MJ
    Cancer Genet Cytogenet; 2005 Oct; 162(2):122-6. PubMed ID: 16213359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of cytogenetic and molecular genetic detection of t(8;21) and inv(16) in a prospective series of adults with de novo acute myeloid leukemia: a Cancer and Leukemia Group B Study.
    Mrózek K; Prior TW; Edwards C; Marcucci G; Carroll AJ; Snyder PJ; Koduru PR; Theil KS; Pettenati MJ; Archer KJ; Caligiuri MA; Vardiman JW; Kolitz JE; Larson RA; Bloomfield CD
    J Clin Oncol; 2001 May; 19(9):2482-92. PubMed ID: 11331327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.